This alert addresses the use of an illicit substance thought to be 3,4-Methylenedioxymethamphetamine (MDMA), also known as Ecstasy or Molly, but which actually contained a hallucinogenic and ...
This safety notice is to raise awareness of two different insulin aspart formulations, namely Fiasp® and NovoRapid®. Fiasp® has a faster onset of action than NovoRapid® and a delay in food intake ...
This alert discusses the dosing errors that can occur with the Xarelto® (rivaroxaban) Starter Kit. The starter pack contains tablets with two different strengths; included are 42 tablets of 15 mg ...